Matthew Sarabura
businessMale0.0Global Dominance: 0.00%
Matthew Sarabura is the national payer manager at Celltrion, a global drugmaker based in South Korea with offices in Canada, and he was recently in the news regarding the delays in the approval of three biosimilar drugs submitted to Health Canada.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Matthew Sarabura, national payer manager at Celltrion, said the company expected to have all three drugs ready for patients this June.
Health Canada says it is working to reduce backlog of lower-cost biosimilar drug submissionsThe Globe and Mail·
Canada· 2025-09-05
Canada· 2025-09-05
